Sixteen-year longitudinal changes in serum prostate-specific antigen levels: The Olmsted County study

Steven J. Jacobsen, Debra J. Jacobson, Michaela E. McGree, Jennifer St. Sauver, George G. Klee, Cynthia J. Girman, Michael M. Lieber

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To determine the distribution of longitudinal changes in serum prostate-specific antigen (PSA) levels from a population-based sample of men. Patients and Methods: In this prospective cohort study, a random sample of Olmsted County, Minnesota, men aged 40 to 79 years in 1990 were followed up biennially from January 1, 1990, through August 29, 2007. Serum PSA levels were determined at each examination, and men were censored for follow-up with a diagnosis of prostate cancer or treatment for benign prostatic hyperplasia. The empirical distributions of annual percent change and annual absolute change in serum PSA level were calculated and tabulated, including the median and 75th and 95th percentiles. Results: For men with PSA measurements 2 years apart, the median annual percent change in serum PSA level was 4.83% and the 95th percentile was about 49.76%. The variability in estimated annual change decreased with increasing time between assessments, with a 95th percentile of 21.82% after 8 or more years between assessments. Although the median absolute change per year increased with increasing age, the median percent change per year was fairly consistent across age groups. Conclusion: These data demonstrate that, with shorter intervals between assessments, greater variability should be expected. These distributions should prove helpful to patients and clinicians in interpreting changes in serum PSA levels observed in typical clinical practices.

Original languageEnglish (US)
Pages (from-to)34-40
Number of pages7
JournalMayo Clinic Proceedings
Volume87
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Prostate-Specific Antigen
Serum
Prostatic Hyperplasia
Prostatic Neoplasms
Cohort Studies
Age Groups
Prospective Studies
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sixteen-year longitudinal changes in serum prostate-specific antigen levels : The Olmsted County study. / Jacobsen, Steven J.; Jacobson, Debra J.; McGree, Michaela E.; St. Sauver, Jennifer; Klee, George G.; Girman, Cynthia J.; Lieber, Michael M.

In: Mayo Clinic Proceedings, Vol. 87, No. 1, 2012, p. 34-40.

Research output: Contribution to journalArticle

Jacobsen, Steven J. ; Jacobson, Debra J. ; McGree, Michaela E. ; St. Sauver, Jennifer ; Klee, George G. ; Girman, Cynthia J. ; Lieber, Michael M. / Sixteen-year longitudinal changes in serum prostate-specific antigen levels : The Olmsted County study. In: Mayo Clinic Proceedings. 2012 ; Vol. 87, No. 1. pp. 34-40.
@article{9c3fda1202d949ee948c75d30f5f47b0,
title = "Sixteen-year longitudinal changes in serum prostate-specific antigen levels: The Olmsted County study",
abstract = "Objective: To determine the distribution of longitudinal changes in serum prostate-specific antigen (PSA) levels from a population-based sample of men. Patients and Methods: In this prospective cohort study, a random sample of Olmsted County, Minnesota, men aged 40 to 79 years in 1990 were followed up biennially from January 1, 1990, through August 29, 2007. Serum PSA levels were determined at each examination, and men were censored for follow-up with a diagnosis of prostate cancer or treatment for benign prostatic hyperplasia. The empirical distributions of annual percent change and annual absolute change in serum PSA level were calculated and tabulated, including the median and 75th and 95th percentiles. Results: For men with PSA measurements 2 years apart, the median annual percent change in serum PSA level was 4.83{\%} and the 95th percentile was about 49.76{\%}. The variability in estimated annual change decreased with increasing time between assessments, with a 95th percentile of 21.82{\%} after 8 or more years between assessments. Although the median absolute change per year increased with increasing age, the median percent change per year was fairly consistent across age groups. Conclusion: These data demonstrate that, with shorter intervals between assessments, greater variability should be expected. These distributions should prove helpful to patients and clinicians in interpreting changes in serum PSA levels observed in typical clinical practices.",
author = "Jacobsen, {Steven J.} and Jacobson, {Debra J.} and McGree, {Michaela E.} and {St. Sauver}, Jennifer and Klee, {George G.} and Girman, {Cynthia J.} and Lieber, {Michael M.}",
year = "2012",
doi = "10.1016/j.mayocp.2011.09.002",
language = "English (US)",
volume = "87",
pages = "34--40",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "1",

}

TY - JOUR

T1 - Sixteen-year longitudinal changes in serum prostate-specific antigen levels

T2 - The Olmsted County study

AU - Jacobsen, Steven J.

AU - Jacobson, Debra J.

AU - McGree, Michaela E.

AU - St. Sauver, Jennifer

AU - Klee, George G.

AU - Girman, Cynthia J.

AU - Lieber, Michael M.

PY - 2012

Y1 - 2012

N2 - Objective: To determine the distribution of longitudinal changes in serum prostate-specific antigen (PSA) levels from a population-based sample of men. Patients and Methods: In this prospective cohort study, a random sample of Olmsted County, Minnesota, men aged 40 to 79 years in 1990 were followed up biennially from January 1, 1990, through August 29, 2007. Serum PSA levels were determined at each examination, and men were censored for follow-up with a diagnosis of prostate cancer or treatment for benign prostatic hyperplasia. The empirical distributions of annual percent change and annual absolute change in serum PSA level were calculated and tabulated, including the median and 75th and 95th percentiles. Results: For men with PSA measurements 2 years apart, the median annual percent change in serum PSA level was 4.83% and the 95th percentile was about 49.76%. The variability in estimated annual change decreased with increasing time between assessments, with a 95th percentile of 21.82% after 8 or more years between assessments. Although the median absolute change per year increased with increasing age, the median percent change per year was fairly consistent across age groups. Conclusion: These data demonstrate that, with shorter intervals between assessments, greater variability should be expected. These distributions should prove helpful to patients and clinicians in interpreting changes in serum PSA levels observed in typical clinical practices.

AB - Objective: To determine the distribution of longitudinal changes in serum prostate-specific antigen (PSA) levels from a population-based sample of men. Patients and Methods: In this prospective cohort study, a random sample of Olmsted County, Minnesota, men aged 40 to 79 years in 1990 were followed up biennially from January 1, 1990, through August 29, 2007. Serum PSA levels were determined at each examination, and men were censored for follow-up with a diagnosis of prostate cancer or treatment for benign prostatic hyperplasia. The empirical distributions of annual percent change and annual absolute change in serum PSA level were calculated and tabulated, including the median and 75th and 95th percentiles. Results: For men with PSA measurements 2 years apart, the median annual percent change in serum PSA level was 4.83% and the 95th percentile was about 49.76%. The variability in estimated annual change decreased with increasing time between assessments, with a 95th percentile of 21.82% after 8 or more years between assessments. Although the median absolute change per year increased with increasing age, the median percent change per year was fairly consistent across age groups. Conclusion: These data demonstrate that, with shorter intervals between assessments, greater variability should be expected. These distributions should prove helpful to patients and clinicians in interpreting changes in serum PSA levels observed in typical clinical practices.

UR - http://www.scopus.com/inward/record.url?scp=84855712723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855712723&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2011.09.002

DO - 10.1016/j.mayocp.2011.09.002

M3 - Article

C2 - 22212966

AN - SCOPUS:84855712723

VL - 87

SP - 34

EP - 40

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 1

ER -